CF
57
-2
ADT
53
3
PRGO
39
3
ORCL
65
-2
PNC
64
4
COF
60
2
CVX
47
3
MHK
49
4
JWN
48
6
CL
58
2
PSA
58
2
DG
6
2
CSX
60
3
HCP
66
8
LLY
37
-3
TJX
64
2
EQIX
64
2
DNB
82
4
ADSK
70
2
DRI
53
5
CF
57
-2
ADT
53
3
PRGO
39
3
ORCL
65
-2
PNC
64
4
COF
60
2
CVX
47
3
MHK
49
4
JWN
48
6
CL
58
2
PSA
58
2
DG
6
2
CSX
60
3
HCP
66
8
LLY
37
-3
TJX
64
2
EQIX
64
2
DNB
82
4
ADSK
70
2
DRI
53
5
Financhill
Back

Allurion Technologies Vs. Perspective Therapeutics Industry Stock Comparison

Sell
13

ALUR
Allurion Technologies

Last Price:
0.43
Seasonality Move:
-34.04%
Sell
30

CATX
Perspective Therapeutics

Last Price:
3.49
Seasonality Move:
34.33%
Sell
13
Allurion Technologies (ALUR) is a Sell

Is Allurion Technologies a Buy, Sell or Hold?

  • The current Allurion Technologies [ALUR] share price is $0.43. The Score for ALUR is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
  • ALUR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.47. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ALUR Stock Price Chart

What is Allurion Technologies's stock price today?

  • The Allurion Technologies share price today is $0.43
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALUR is experiencing selling pressure, which indicates risk of future bearish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALUR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 36.42 Sell
Chaikin Money Flow: -311621 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.49 - 0.77) Sell
Bollinger Bands (100): (0.56 - 0.88) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.06 Sell
Relative Strength Index (14 RSI): 14.31 Sell
Chaikin Money Flow: 5909257 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.39 - 12.93) Sell
Bollinger Bands (100): (10.25 - 14.79) Sell

ALUR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.43 Sell
20-day SMA: 0.61 Sell
50-day SMA: 0.65 Sell
200-day SMA: 1.42 Sell
8-day EMA: 0.48 Sell
20-day EMA: 0.56 Sell
50-day EMA: 0.65 Sell
200-day EMA: 1.52 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.64 Sell
20-day SMA: 9.7 Sell
50-day SMA: 11.58 Sell
200-day SMA: 12.72 Sell
8-day EMA: 6.25 Sell
20-day EMA: 8.74 Sell
50-day EMA: 10.88 Sell
200-day EMA: 11.36 Sell

Allurion Technologies Earnings Growth & ALUR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.68 per share, and an increase next year of $0.10 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

Allurion Technologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):